Skip to content
healthcare.dev

Ranolazine

NDC 68462-319, RANOLAZINE, tablet, film coated, extended release, from Glenmark Pharmaceuticals Inc., USA.

Product NDC
68462-319
Status
Listed
Labeler
Glenmark Pharmaceuticals Inc., USA
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211082
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68462-319 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
68462-319-0568462031905500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-319-05)
68462-319-606846203196060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-319-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0cf58732-c242-49b0-8e3f-248778b4458d
  • NADAC price for package 68462031960

    GET /v1/drugs/nadac/68462031960

Use it

Look up 68462-319 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68462-319 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68462-319. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.